Diagnostics software company leveraging ECGs as a broad biomarker with applications in cardiology and beyond to improve outcomes and save lives. Our FDA-cleared Class II SaMD, AccurECG, delivers fully automated, near real-time interpretation, improving analysis time, accuracy, and patient care. By leveraging AI, we extend the utility of ECGs to detect critical conditions beyond typical clinical use, such as Aortic Stenosis and more, transforming patient outcomes. Part of 2024 Medtech Innovator.